CDX-0125-TEI

N/A

Report date: 2024/02/05 14:00:27

Base Information

Drug NameCDX-0125-TEI

Drug Alias NameCDX-0125-TEI

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Cleavable peptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > NMS-P528 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnaplastic lymphoma kinase inhibitors

TargetsAnaplastic lymphoma kinase

Therapy Area/IndicationsNeuroblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelldex Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesCelldex Therapeutics

Inactive CompaniesN/A

Active IndicationsNeuroblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A